AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 171 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,040 | -18.2% | 350 | 0.0% | 0.00% | – |
Q4 2022 | $9,828 | -10.7% | 350 | +75.0% | 0.00% | – |
Q2 2021 | $11,000 | +22.2% | 200 | 0.0% | 0.00% | – |
Q4 2020 | $9,000 | -74.3% | 200 | -80.0% | 0.00% | -100.0% |
Q3 2020 | $35,000 | -2.8% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $36,000 | -25.0% | 1,000 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $48,000 | +1100.0% | 1,000 | +1150.0% | 0.00% | – |
Q3 2019 | $4,000 | 0.0% | 80 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | -20.0% | 80 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | +25.0% | 80 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -33.3% | 80 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | -14.3% | 80 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $7,000 | 0.0% | 80 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $7,000 | +40.0% | 80 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | +150.0% | 80 | +166.7% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |